bioPharmaceuticals

Mission: Commercialization of cutting-edge, affordable health care solutions through global partnering programs from India. 

Avesthagen has embarked on a programme to identify promising, early stage biopharmaceutical candidates across the globe that can be co-developed in India. The areas currently pursued for such product development programmes include therapeutics and diagnostics in cancer and autoimmune disorders. In addition Avesthagen has also developed a strong pipeline of biosimilars that will address specific therapeutic segments.

The core competencies in biopharmaceutical R & D include:

• Generation of stable mammalian cell lines over-expressing a recombinant protein

• Development of product specific bioassays

• Design of novel animal component free production media

Discovery and development engine at Avesthagen

• Research - Pathway engineering and development of novel expression systems

• Development – Proprietary expression platforms and novel, scalable processes in microbial and mammalian systems

• Manufacture - Scale-up, manufacture and supply of clinical grade material through ABRPL

• Co-development opportunities - Development of Novel Biological Entities in India

Drug discovery services

• Development & supply of cell-lines over-expressing drug targets

• Development and screening of compounds through cell based & biochemical assays

• Supply of laboratory grade proteins & antibodies 

• Metabolomics for SAR studies